Current Knowledge and Perspectives for Pharmacological Treatment in OSA
- 6 January 2022
- journal article
- editorial
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 58 (10) , 681-684
Abstract
No abstract availableFunding Information
- National Health and Medical Research Council
- French National Research Agency
This publication has 27 references indexed in Scilit:
- The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover TrialAmerican Journal of Respiratory and Critical Care Medicine, 2019
- The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea. An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Incorporating polysomnography into obstructive sleep apnoea phenotyping: moving towards personalised medicine for OSAThorax, 2018
- Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trialInternational Journal of Obesity, 2016
- Obstructive sleep apnoea syndromeNature Reviews Disease Primers, 2015
- Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled studyEuropean Respiratory Journal, 2014
- Defining Phenotypic Causes of Obstructive Sleep Apnea. Identification of Novel Therapeutic TargetsAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Residual sleepiness in sleep apnea patients treated by continuous positive airway pressureJournal of Sleep Research, 2013
- Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoeaThe Journal of Physiology, 2013
- Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoeaThe Journal of Physiology, 2012